CLINICAL_TRIALS
research
· 2026-01-22
Clinical Trial Update: Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not [NA]
Summary
This clinical trial in pancreatic neuroendocrine tumor is evaluating whether optimal surgical debulking provides benefit. It is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Uppsala University | Conditions: Pancreatic Neuroendocrine Tumor | NA | Status: RECRUITING